" class="no-js "lang="en-US"> ADARx Pharmaceuticals - Pharmtech Focus
Thursday, January 26, 2023
ADARx Pharmaceuticals | PTF

ADARx Pharmaceuticals

About ADARx Pharmaceuticals

ADARx Pharmaceuticals
ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated and central nervous system diseases.

Related Story

ADARx Pharmaceuticals Raises $46 Million in Financing as Lead Product Enters the Clinic

January 23 2023

ADARx Pharmaceuticals, a clinical-stage biotechnology company developing RNA-targeting therapeutics, has announced the close of a […]